Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
about
Multiscale Mechano-Biological Finite Element Modelling of Oncoplastic Breast Surgery-Numerical Study towards Surgical Planning and Cosmetic Outcome PredictionRelative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).Indicators based on registers and administrative data for breast cancer: routine evaluation of oncologic care pathway can be implemented.Survival of Node-negative Breast Cancer Patients Treated at the University Medical Centre Maribor in the Period 2000-2009.Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.Breast cancer survival in Germany: a population-based high resolution study from SaarlandTreatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and IrelandThioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.New analysis reexamines the value of cancer care in the United States compared to Western EuropeA review of breast cancer care and outcomes in Latin America.Breast cancer after kidney transplantation: a single institution review.Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practiceDelay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor MarkersComparing cancer care, outcomes, and costs across health systems: charting the course.The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases.Comparative cancer survival in European countries.Management of locally advanced breast cancer-perspectives and future directions.Cancer survival in China, 2003-2005: a population-based study.Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme.The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study.Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13.18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02).CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014.Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study
P2860
Q27333186-A54D6D1E-2DDE-43BF-B3A8-2E5F2416252CQ30844605-16AD191F-9A4A-42F3-B7F3-205C244E3BDCQ30873972-15FFCFE9-3D4F-4325-97A7-F814EAC0D87AQ30988296-E62B1A63-830E-4114-98AD-FCFCAAB5EFBDQ33891746-8C925D68-86B4-4409-A0D6-ED0A0AF7FB49Q34423099-BE9D6EE7-5662-4EB6-B81C-4AB0687CE5D0Q34707461-F9426B70-7BA2-46CE-B30F-107E6D2716A1Q34923369-063C2ACE-9235-4EC4-AF4E-6D078C54947BQ35043918-9CC4BFDE-5ED4-46BA-B78C-2C3681ED06D3Q35083870-3C1CE325-D0B2-4545-8DF4-4BE7522F8010Q35621404-51001909-5D13-458E-94D9-34C468A742DEQ36714364-355774BC-E032-4D3C-8ED5-A899E689F197Q36735764-468A2311-4D43-4AF1-A986-8687506D38ACQ36746804-FCD5DAF1-FAD1-47E5-97E6-C0821FF6A4E4Q36754437-A2C44E92-36FB-4826-A2F1-E433463BEF26Q36908374-041758A4-23CB-493F-BF68-801374E3ECC9Q36929466-E027FB03-28E2-4504-A109-167ADBBC49E3Q37383675-C37DEE28-838A-46C7-8D08-3435903D72B7Q37520235-34CDD755-97BB-433E-A1CE-BC95F167EC39Q38210849-B9289700-98C7-4C89-907D-D992CC660542Q38350939-8BC06A78-605A-492F-8CFA-D5EFE86AA3FBQ39125586-6FC8DEE6-14C7-40AE-8D9B-F1C85947BB12Q41253382-339A6597-8BBF-4CA0-9FDF-54CCB01EC03DQ45328775-F41FA4E2-273A-4125-AC0C-06C141A56766Q45729931-3DD029A6-564D-4660-86FF-A30F413EB8A6Q46160342-5EBC0CA3-9AD9-40A3-AAA6-579277709F04Q47138958-F6F6641D-F161-4391-B254-9EEA1BAD695EQ48082945-B2818D71-A721-47FF-B1FA-B74D051B147BQ50100711-1DC196D7-A015-434C-8E3A-DD16E6C390A9Q50127275-8D5DA0EF-45D0-498C-AE91-74A495F9E137Q52849107-E734C5D7-7735-456B-B90D-43360FD1EECFQ53213608-A71CFF23-6C75-4EE0-8B30-D20499E69E67Q55491659-25C4AD0D-184A-4919-86F1-24D7D3B2D05EQ58803134-96A4388E-72C5-43C5-8AF8-3E3FC785523C
P2860
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@ast
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@en
type
label
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@ast
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@en
prefLabel
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@ast
Breast cancer survival in the US and Europe: a CONCORD high-resolution study.
@en
P2093
P2860
P50
P356
P1476
Breast cancer survival in the US and Europe: a CONCORD high-resolution study
@en
P2093
Adele Traina
Ana Torrella-Ramos
Anne-Sophie Woronoff
Chakameh Safaei Diba
Claudia Allemani
Claudia Cirilli
Eva Ardanaz
Hannah K Weir
Holly J Wolf
Jadwiga Rachtan
P2860
P304
P356
10.1002/IJC.27725
P50
P577
2012-09-18T00:00:00Z